The Global digital polymerase chain reaction (dPCR) market is anticipated to grow from $ 276 million in 2016 to $3812 million by 2025, at a CAGR of 32.68% between 2016 and 2025. The digital polymerase chain reaction market is fast expanding and developing on the global scenario. The digital PCR plays a vital role in the accurate computation of nucleic acids. The digital polymerase chain reaction (dPCR) market is primarily driven by following factors:

• Increasing incidents of genetic disorders and infectious diseases
• Increasing elderly population
• Rising geriatric population
• Increasing private-public grants and investments
• Rise in the number of hospitals and diagnostics centers

The important driver increasing the growth of the global digital polymerase chain reaction (dPCR) market is the increasing incidents of genetic disorders and infectious diseases. Increasing pollution around the globe attributes to rising in infectious diseases like malaria, tuberculosis, chicken pox, AIDS and genetic disorders like cancer, cystic fibrosis etc.  Identification of these diseases plays a key role in the healthcare sector for curing the disease

Digital PCR market by application is very large and highly diversified. The clinical segment of digital PCR market by application is one of the fastest growing segments across the world. The growth can be attributed to continuous technological up-gradation, its cost-effectiveness, growing popularity among hospitals and diagnostic centers, and the rising cases of genetic disorders, cancer, and AIDS globally. The popular research application of digital PCR includes gene expression, pathogen detection, microbiome analysis, and next generation sequencing. Digital PCR has a positive impact on various life sciences fields such as bioengineering, genetic engineering, and neurosciences and thus it is highly adopted by research and development sector across the world. The forensic discipline of science is one of the most promising tools used in investigating the crime and criminal behind that. Digital PCR plays a very important role in it and thus has various applications in the forensic sector as well; such as DNA fingerprinting, gene sequencing, DNA profiling.

High Device Costs Associated with dPCR is the major factors hindering the market. Though dPCR technologies provide a high degree of accuracy and specificity in the diagnosis of diseases and the development of personalized medicine, patients with low income cannot afford this technology, resulting in patient non-compliance. Additionally, small biotechnological companies and research institutes also work on a limited budget. Thus, the high cost of dPCR products could limit the growth of the Global dPCR market.

The Global digital polymerase chain reaction (dPCR) market segments include end users, applications, and products and services.

End users are further segmented into:

• Research & Academic Institution
• Pharmaceuticals & Biotechnology
• Clinical Research Organization
• Forensic Laboratories

Applications are further segmented into:

• Clinical
• Research
• Forensic

Products & Services are further segmented into:

• Instruments
• Reagents & Consumables
• Software & Services

This report covers the present market conditions and the growth prospects of the global digital polymerase chain reaction (dPCR) market for 2017-2025 and considered the revenue generated through the sales of digital polymerase chain reaction (dPCR)  for the end user as well as applications to calculate the market size by considering 2016 as the base year.

Geographically, the global digital polymerase chain reaction (dPCR) market has been segmented on the basis of four major regions, which include:

• Digital polymerase chain reaction North America Market – U.S. & Canada
• Digital polymerase chain reaction Asia-Pacific Market – China, India, Japan, Rest of APAC
• Digital polymerase chain reaction  Europe Market – UK, France, Germany, Spain, Rest of Europe
• Rest of World- Latin America, Middle East and Africa

The digital polymerase chain reaction (dPCR) market in North America is expected to hold the largest share by 2025 because of the possibilities of increase in geriatric population. Rising incidences of infectious diseases and genetic disorders that are resulting in increased deaths are stimulating the growth of digital PCR market. North America is driven by factors such as an increase in public and private funding for the development of R&D innovation in digital PCR products and the rising number of hospitals and diagnostic centers. On the other hand, the Asia-Pacific market is anticipated to be the fastest-growing region for the digital polymerase chain reaction (dPCR) market over the forecast period. The market is primarily driven by the rising geriatric population, increasing incidence of infectious diseases and genetic disorders, increasing public and private investments and grants and due to the growing number of hospitals and diagnostic centers.

The digital polymerase chain reaction (dPCR) Market is segmented based on end user which is sub-divided into Research & Academic Institution, Pharmaceuticals & Biotechnology, Clinical Research Organization and Forensic Laboratories; on the basis of applications which is sub-divided into Clinical, Research and Forensics; and on the basis of Products & Services which is sub-divided into Instruments, Reagents & Consumables and Software & Services. The instruments for digital PCR include Quant Studio 3D digital PCR system, PCR enzymes & master mixes, thermal cyclers & real-time PCR instruments, reverse transcription, PCR tubes, plates & accessories. Global digital PCR market has enormous systems such as Q X 200 droplet digital PCR system, C FX96 Touch real-time PCR detection system, CFX automation system for real-time PCR and they provide the absolute quantification of target RNA or DNA molecules. There are various research laboratories which are practicing digital PCR technologies and manufacturing drugs which are prescribed for cancer treatment. Clinical research plays a very important role in healthcare market since it gives the proof of drug effectiveness and only after the approval given by clinical research organization does the drug come into the market.

The major market players of the global digital polymerase chain reaction (dPCR) market are:

• Thermo Fisher Scientific Inc.
• Agilent Technologies, Inc.
• Bio-Rad Laboratories, Inc.
• Hoffmann-La Roche Ltd
• Affymetrix, Inc.

Company Profiles covers analysis of important players.

Thermo Fisher Scientific Inc. (Thermo Fisher Scientific or ‘the company’) is a manufacturer and developer of equipment, reagents and consumables, analytical instruments, software and services for research, discovery, analysis, manufacturing, and diagnostics. F. Hoffmann-La Roche Ltd (Roche or ‘the group’) is one of the leading research-focused healthcare groups in the world. It is engaged in the discovery, development, and commercialization of innovative therapeutic and diagnostic products.

Key Findings of the Global Digital polymerase chain reaction (dPCR) market:

• North America is the market leader of digital PCR
• China is the largest healthcare drugs and equipment market in Asia-pacific
• Research market is the largest application of digital PCR
• Instrument market to be the fastest growing market by products and services